Bone-marrow-aspirate-concentrate for chondral defects: surgical techniques, clinical applications and basic science

Mesenchymal stem or progenitor cells remain the cells of choice for many regenerative treatment strategies in orthopedics. Due to a number of reasons such as regulatory burdens, time- and cost-efficiency and patient safety, bone-marrow-aspirate-concentrate (BMAC) has become an increasingly important source for application of mesenchymal stem cells (MSCs). However, specific surgical application techniques, as well as treatment regimes, often remain poorly discussed in the literature. This article aims to bridge this gap by providing comprehensive information for practicing surgeons to ease patient selection and clinical application of BMAC for chondral defects.

• Publication year

  2018

• Venue

  Annals of Joint

• Publication date

  2018-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21037/AOJ.2018.11.03
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Bone Marrow Aspirate Concentrate Harvest and Delivery With a Neonatal Nasogastric Tube: A Simple Technique in Hip Arthroscopy

  2025cites this paper
• A New Approach to Postoperative Rehabilitation following Mosaicplasty and Bone Marrow Aspiration Concentrate (BMAC) Augmentation

  2024cites this paper
• Adipose derived stem cells to target osteoarthritis: Basic science and clinical applications

  2023cites this paper
• Isolation and Cultivation of Adipose-Derived Mesenchymal Stem Cells Originating from the Infrapatellar Fat Pad Differentiated with Blood Products: Method and Protocol

  2022cites this paper
• Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate

  2022cites this paper
• Biological perspectives and current biofabrication strategies in osteochondral tissue engineering

  2020cites this paper
• The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations

  2019cites this paper